Wednesday, July 8, 2026

pharma · Acute Pain · Pharmacokinetics · ENSC

Ensysce Biosciences

Ensysce Biosciences drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

La Jolla, USA HQ
2008 Founded
13 Employees
Public company Type
ENSC · NYSE Ticker
Company details
Status
Public
HQ
La Jolla, USA
Founded
2008
Employees
13
Programs
6
Drugs
2
Patents
2
Intelligence · Drug Pipeline

Ensysce Biosciences pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Ensysce Biosciences drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to Ensysce Biosciences in public FDA and regional records.

  2. Development asset linked to Ensysce Biosciences in public FDA and regional records.